// App-Quantinova.ai

: Biological Characterization and Differential Gene Expression Analysis of CYT-338 NK Cell Engager (NKE) Against CD38 Expressing Tumors Including Multiple Myeloma (MM)

Researchers

Presenter

  • Liang Lin

Principal Investigators

  • Hao-Ming Chang

  • Dennis Wu

  • Ben Titz

  • Amy Chen

  • Marshall Chao Ma

  • Preeti Ashok

  • David Zou

  • Nejmi Dilmac

  • Armand Bensussan

  • Jean Kadouche

  • Chorom Pak

  • Stanley Frankel

  • Daniel Teper

  • Wei Li

  • Antonio Arulanandam

Medical Centers

  • Paris University, INSERM, UMR-, Institut de Recherche Saint-Louis, Paris, France

  • Cytovia Therapeutics, Natick, MA

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 38

Drug/Treatment

  • daratumumab Intravenous

  • Tamsulosin Hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A